Eric Morgen

Insider Reports History

Location
Richmond, CA
Signature
/s/ Dov A. Goldstein as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Morgen:

Company Role Class Num Shares Value Price $ Report Date Ownership
BioAge Labs, Inc. Chief Operating Officer, Director Stock Option (Right to Buy) 110,000 17 Feb 2026 Direct
BioAge Labs, Inc. Chief Operating Officer, Director Stock Option (Right to Buy) 12,500 17 Feb 2026 By Spouse

Insider Reports Filed by Eric Morgen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BIOA BioAge Labs, Inc. 17 Feb 2026 2 $0 4 Chief Operating Officer, Director 19 Feb 2026, 16:40
BIOA BioAge Labs, Inc. 18 Feb 2025 1 $0 4/A Chief Operating Officer, Director 25 Feb 2025, 16:28
BIOA BioAge Labs, Inc. 25 Sep 2024 0 $0 3 Chief Operating Officer, Director 25 Sep 2024, 16:47
BIOA BioAge Labs, Inc. 17 Apr 2024 3 $0 4 Chief Operating Officer, Director 27 Sep 2024, 16:17